Description :
ODM-201 is a new-generation, potent and selective androgen receptor (AR) inhibitor which is potential useful for treatment of castration-resistant prostate cancer (CRPC). ODM-201 is a full and high-affinity AR antagonist that, similar to second-generation antiandrogens enzalutamide and ARN-509, inhibits testosterone-induced nuclear translocation of AR.
Molecular Weight :389.85
Purity :98%
Molecular Formula :
C19H19ClN6O2
Canonical SMILES :
Darolutamide
+1 additional providers that we know from the past